Primary CKD Screening in the General Population Not Cost-Effective

Share this content:

A new systematic literature review has found that it may not be cost-effective to provide primary screening for chronic kidney disease (CKD) in the general population.

However, primary CKD prevention screening does appear to be cost-effective in patients with diabetes and hypertension.

John Schieszer has the latest on the story in today's Medical Minute.

You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters